bpc-157 henderson Peptide Therapy Las Vegas BPC-157 – Mark Hyman, MD

BPC-157 is a pentadecapeptide derived from the stomach that operates via an intricate network of cytoprotection and angiogenesis mechanisms, including VEGFR2, NO-eNOS signaling, FAK-paxillin interaction and others, with its most solid data being derived from gastrointestinal, tendon, ligament, bone, and increasingly neural studies

doi: 10.1208/s12249-017-0844-8

doi:10.1016/bs.vh.2022.01.001

Epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years

Unfortunately, veterinary application, trials, and research in dogs are still 510 years behind human medicine, but interest in the field is rapidly accelerating

Lipotropic compounds interact with fat metabolism by either hastening the removal or decreasing the amount of fat in the liver